Role of VaraSpan in Alleviating Menopause-Related Conditions - Varalife®

Role of VaraSpan in Alleviating Menopause-Related Conditions


Menopause is a natural biological process that marks the end of a woman's reproductive years. It typically occurs in midlife, usually between the ages of 45 and 55, although the exact timing can vary for each individual. Menopause is characterized by the cessation of menstrual periods, signaling the end of the woman's ability to conceive naturally. This transition occurs due to a decline in the production of estrogen and progesterone, the hormones responsible for regulating the menstrual cycle and supporting fertility. 

Menopause marks a significant transition in a woman's life, often accompanied by a variety of uncomfortable symptoms such as hot flashes, mood swings, and sleep disturbances. While hormone replacement therapy (HRT) has been a conventional approach to manage these symptoms, concerns regarding its safety have led many women to seek alternative solutions. One such promising avenue is Nicotinamide Mononucleotide (NMN), a compound gaining attention for its potential benefits in mitigating menopause-related conditions. In this blog, we delve into the scientific literature to explore how NMN may offer relief during this transitional phase. 

Understanding NMN  

Nicotinamide Mononucleotide (NMN) is a precursor to Nicotinamide Adenine Dinucleotide (NAD+), a coenzyme involved in various cellular processes, including energy metabolism and DNA repair. As we age, NAD+ levels decline, leading to impaired cellular function and increased susceptibility to age-related diseases. NMN supplementation aims to boost NAD+ levels, thereby potentially mitigating age-related decline and associated conditions. 

Types of Menopauses 

Perimenopause typically precedes menopause, characterized by a decline in hormonal levels. This shift leads to irregular menstrual periods and the onset of menopausal symptoms like hot flashes and vaginal dryness. Women may also notice changes in their menstrual cycles during this transition, known as the menopausal changeover. 

Menopause marks the cessation of hormonal production responsible for the monthly menstrual cycle. It is confirmed when a woman has gone 12 consecutive months without menstruation. 

Post-menopause follows menopause and extends throughout the remainder of a woman's life. During this stage, women are at increased risk of health issues such as osteoporosis and heart disease. 


NMN and Menopause-Related Symptoms 

Hot Flashes and Vasomotor Symptoms: Hot flashes are among the most common and distressing symptoms experienced during menopause. A study published in "Cell Reports" in 2019 explored the role of NAD+ in regulating temperature sensitivity in mice. The findings suggest that NAD+ levels influence thermoregulation, indicating a potential link between NAD+ modulation and hot flash alleviation. 

Mood Swings and Cognitive Function: Menopause often coincides with changes in mood and cognitive function, which can significantly impact a woman's quality of life. NMN's role in enhancing cellular energy production and supporting neuronal function has garnered interest in its potential to alleviate mood swings and cognitive decline. A study published in "Nature Communications" in 2020 demonstrated that NMN supplementation improved cognitive function and reduced neuronal damage in aging mice, suggesting its neuroprotective effects. 

Sleep Disturbances:
Sleep disturbances are prevalent among menopausal women, contributing to fatigue and impaired daytime functioning. NAD+ has been implicated in regulating circadian rhythms and sleep-wake cycles. A study published in "Cell Metabolism" in 2016 highlighted the role of NAD+ metabolism in modulating sleep patterns in mice. While direct evidence linking NMN supplementation to improved sleep in menopausal women is limited, these findings underscore the potential relevance of NAD+ modulation in addressing sleep disturbances. 

    Safety and Considerations 

    While the research on NMN's efficacy in alleviating menopause-related symptoms is promising, it's essential to approach supplementation with caution and one should consider safe-for-all dosages of 250mg per day. 


    Nicotinamide Mononucleotide (NMN) holds promise as a novel approach to addressing menopause-related symptoms by targeting cellular mechanisms implicated in aging and age-related conditions. While preliminary studies suggest potential benefits in alleviating hot flashes, mood swings, and sleep disturbances, further research is needed to elucidate NMN's role in managing menopausal symptoms comprehensively. As scientific understanding advances, NMN supplementation may emerge as a valuable adjunctive therapy for women navigating the menopausal transition, offering a ray of hope amidst the challenges of this transformative phase. 


    • Gariani, Karim, et al. "Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice." Hepatology, vol. 63, no. 4, 2016, pp. 1190-1204. 
    • Mills, Kathryn F., et al. "Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice." Cell Metabolism, vol. 24, no. 6, 2016, pp. 795-806. 
    • Yoshino, Jun, et al. "Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice." Cell Metabolism, vol. 14, no. 4, 2011, pp. 528-536. 
    • Zhang, Hua, et al. "NAD⁺ repletion improves mitochondrial and stem cell function and enhances life span in mice." Science, vol. 352, no. 6292, 2016, pp. 1436-1443. 
      View All Blogs